Jay D Raman Selected Research

Methyltransferases

1/2020	Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.
7/2018	Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jay D Raman Research Topics

Disease

89	Carcinoma (Carcinomatosis) 02/2024 - 03/2006
81	Neoplasms (Cancer) 02/2024 - 12/2005
23	Urinary Bladder Neoplasms (Bladder Cancer) 11/2022 - 12/2005
16	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 12/2006
12	Renal Cell Carcinoma (Grawitz Tumor) 07/2023 - 06/2008
8	Infections 10/2023 - 08/2014
8	Lymphatic Metastasis 01/2020 - 03/2012
6	Chronic Renal Insufficiency 01/2023 - 11/2010
6	Necrosis 01/2017 - 06/2008
5	Neoplasm Metastasis (Metastasis) 07/2023 - 02/2009
3	Hematuria 01/2023 - 01/2021
3	Hydronephrosis 06/2021 - 01/2011
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 04/2008
3	Margins of Excision 01/2020 - 11/2009
3	Urinary Tract Infections (Urinary Tract Infection) 12/2019 - 08/2009
3	Kidney Neoplasms (Kidney Cancer) 01/2019 - 07/2010
3	Carcinoma in Situ 01/2017 - 05/2012
3	Solitary Kidney 02/2010 - 04/2008
2	Hemorrhage 02/2022 - 11/2020
2	Disease Progression 01/2021 - 07/2010
2	Convalescence 08/2020 - 05/2009
2	Lymphadenopathy 01/2020 - 01/2017
2	Sarcopenia 12/2018 - 01/2018
2	Sepsis (Septicemia) 09/2018 - 01/2017
2	Obesity 01/2018 - 05/2008
2	Ischemia 09/2016 - 02/2014
2	Shock 01/2010 - 03/2008
2	Pain (Aches) 09/2009 - 04/2009
2	Transitional Cell Carcinoma 02/2007 - 10/2006
2	Varicocele 06/2005 - 11/2004
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	COVID-19 10/2021
1	Postoperative Pain 11/2020
1	Adenocarcinoma 01/2020
1	Anemia 01/2020

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2009
6	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 10/2006
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2005
5	Transcription Factors (Transcription Factor)IBA 11/2022 - 02/2017
5	Phenobarbital (Luminal)FDA Link 01/2021 - 12/2016
5	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2018
5	Messenger RNA (mRNA)IBA 01/2020 - 12/2005
4	Prostate-Specific Antigen (Semenogelase)IBA 03/2021 - 09/2018
3	Hemoglobins (Hemoglobin)IBA 07/2023 - 01/2020
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2022 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 08/2013
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2016
2	PlatinumIBA 02/2024 - 10/2011
2	Local Anti-Infective Agents (Antiseptics)IBA 12/2021 - 09/2018
2	Indicators and Reagents (Reagents)IBA 06/2021 - 04/2010
2	AndrogensIBA 01/2021 - 01/2018
2	Opioid Analgesics (Opioids)IBA 11/2020 - 01/2018
2	CarcinogensIBA 01/2020 - 01/2019
2	MethyltransferasesIBA 01/2020 - 07/2018
2	Enhancer of Zeste Homolog 2 ProteinIBA 07/2018 - 01/2016
2	AntibodiesIBA 12/2017 - 12/2005
2	Povidone-Iodine (Betadine)FDA LinkGeneric 08/2017 - 09/2015
2	FluoroquinolonesIBA 01/2017 - 11/2013
2	TOR Serine-Threonine KinasesIBA 01/2015 - 11/2014
1	SDMIBA 10/2023
1	Serum AlbuminIBA 07/2023
1	mesoglycanIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2022
1	Heavy MetalsIBA 01/2021
1	ChromatinIBA 01/2021
1	Hemostatics (Antihemorrhagics)IBA 11/2020
1	SodiumIBA 01/2020
1	delta proteinIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020

Therapy/Procedure

71	Nephroureterectomy 02/2024 - 10/2006
32	Nephrectomy 07/2023 - 12/2007
27	Therapeutics 01/2021 - 02/2007
15	Drug Therapy (Chemotherapy) 02/2024 - 11/2009
11	Prostatectomy (Retropubic Prostatectomy) 10/2023 - 12/2006
11	Cystectomy 06/2021 - 02/2007
10	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 02/2009
9	Adjuvant Chemotherapy 01/2018 - 07/2008
8	Length of Stay 08/2020 - 10/2006
5	Neoadjuvant Therapy 01/2024 - 03/2012
4	Adrenalectomy 10/2019 - 01/2008
4	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 09/2015 - 03/2008
4	Operative Time 02/2014 - 10/2006
4	Radiofrequency Ablation 02/2010 - 04/2008
3	Catheters 04/2022 - 08/2012
3	Antibiotic Prophylaxis 01/2021 - 01/2015
3	Conservative Treatment 01/2020 - 12/2006
2	Immunotherapy 11/2022 - 07/2010
2	Patient Readmission 01/2021 - 01/2020
2	Conversion to Open Surgery 01/2020 - 10/2007
2	Radiotherapy 08/2012 - 12/2006
2	Aftercare (After-Treatment) 07/2010 - 02/2007
2	Operative Surgical Procedures 09/2009 - 06/2008
1	Cystoscopes 10/2023
1	General Anesthesia 01/2022
1	Transurethral Resection of Bladder 01/2022
1	Telescopes 01/2022
1	Chemoprevention 01/2022
1	Episode of Care 01/2021
1	Retreatment 01/2021